PMA supplement
P930029 S012: ATAKR RADIOFREQUENCY CATHETER ABLATION (RFCA) SYSTEM
FDA PMA supplement · Normal 180 Day Track · Medtronic, Inc.
Key facts
| Original PMA | P930029 |
|---|---|
| Supplement number | S012 |
| Supplement type | Normal 180 Day Track |
| Reason for the supplement | Location Change - Manufacturer/Sterilizer/Packager/Supplier |
| Trade name | ATAKR RADIOFREQUENCY CATHETER ABLATION (RFCA) SYSTEM |
| Generic name | Cardiac ablation percutaneous catheter |
| Applicant | Medtronic, Inc. |
| Product code | LPB |
| Received date | Jun 30, 1998 |
| Decision date | Aug 14, 1998 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: